Crofelemer Patent Expiration
Crofelemer is Used for providing symptomatic relief for non-infectious diarrhea. It was first introduced by Napo Pharmaceuticals Inc
Crofelemer Patents
Given below is the list of patents protecting Crofelemer, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Mytesi | US8962680 | Methods and compositions for treating HIV-associated diarrhea | Oct 31, 2031 | Napo Pharms Inc |
| Mytesi | US9585868 | Methods and compositions for treating HIV-associated diarrhea | Oct 31, 2031 | Napo Pharms Inc |
| Mytesi | US7341744 | Method of treating secretory diarrhea with enteric formulations of proanthocyanidin polymer |
Jun 16, 2018
(Expired) | Napo Pharms Inc |
| Mytesi | US7323195 | Enteric formulations of proanthocyanidin polymer antidiarrheal compositions |
Jun 07, 2018
(Expired) | Napo Pharms Inc |
| Mytesi | US8574634 | Compositions and methods of treatment with proanthocyanidin polymer antidiarrheal compositions |
Jan 11, 2018
(Expired) | Napo Pharms Inc |
Crofelemer's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List